Cutaneous Sarcoidosis Successfully Treated with
Mycophenolate Sodium

Mustapha Djaballah

Case Report

Cutaneous Sarcoidosis Successfully Treated with Mycophenolate Sodium

Cagdas Boyvadoglu¹ and Huseyin Serhat Inaloz²*

¹Department of Dermatology, Ceyhan State Hospital, Adana, Turkey

²Department of Dermatology, University of Gaziantep Faculty of Medicine, Gaziantep, Turkey

Corresponding Author

Received Date: April 06, 2023; Published Date: April 26, 2023

Abstract

Sarcoidosis is a multisystem disorder that can affect practically any organ of the body. Involvement of the skin is the most common extrathoracic manifestation of sarcoidosis. Glucocorticoids are the cornerstone of the treatment of sarcoidosis. The most commonly used disease-modifying antirheumatic drugs (DMARDs) for skin sarcoidosis include hydroxychloroquine, chloroquine, and methotrexate. So far as we know, no cases of cutaneous sarcoidosis treated with mycophenolate have been reported. Mycophenolate therapy stands out among other DMARDs due to its rapid onset of action and limited toxicity. Our case shows that cutaneous sarcoidosis can be successfully treated with mycophenolate therapy.

Keywords: Cutaneus Sarcoidosis; Mycophenolate sodium; Systemic therapy; Case report

Article Details

Citation

Cagdas Boyvadoglu and Huseyin Serhat Inaloz*. Cutaneous Sarcoidosis Successfully Treated with Mycophenolate Sodium. World Journal of Dermatology & Cosmetics. 1(1): 2023. WJDC.MS.ID.000501.